Maintenance therapy in non-small-cell lung cancer.
Stinchcombe
Thomas E
TE
Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. Thomas_Stinchcombe@med.unc.edu
West
Howard L
HL
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000401:mortality; D002945:Cisplatin / Q000627:therapeutic use; D017326:Clinical Trials, Phase III as Topic; D018450:Disease Progression; D005971:Glutamates / Q000627:therapeutic use*; D006147:Guanine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000401:mortality; D000068437:Pemetrexed; D016032:Randomized Controlled Trials as Topic; D015996:Survival Rate
D005971:Glutamates; D000068437:Pemetrexed; D006147:Guanine; D002945:Cisplatin